Streetbeat News

Stock Prices

BBWI

DCI

GME

HPE

NVDA

Investor sentiment showed some improvement but remained neutral as the Dow fell over 100 points due to weak U.S. manufacturing data. NVIDIA and GameStop saw significant gains, while most sectors on the S&P 500 closed negatively. Investors are awaiting earnings results from Donaldson Company, Bath & Body Works, and Hewlett Packard Enterprise.

Portfolio Pulse from Avi Kapoor

June 04, 2024 | 7:23 am

BARK

BBWI

DCI

HPE

HQY

U.S. stock futures are trading lower this morning. Key stocks to watch include Donaldson Company, HealthEquity, Bath & Body Works, BARK, and Hewlett Packard Enterprise. Donaldson is expected to report earnings, HealthEquity reported strong results, Bath & Body Works and Hewlett Packard Enterprise are set to release earnings, and BARK reported disappointing results.

Portfolio Pulse from Avi Kapoor

June 04, 2024 | 7:23 am

AMD

INTC

MSFT

NVDA

Intel announced new Lunar Lake chips with enhanced AI processors aimed at Copilot+ AI PCs and data center chips to compete with AMD. The Lunar Lake series will offer significant improvements in power efficiency and processing power, and is expected to power thin and light laptops by the 2024 holiday season. Intel also introduced new server and AI chips to challenge AMD and Nvidia, with competitive pricing strategies.

Portfolio Pulse from Rounak Jain

June 04, 2024 | 6:29 am

INTC

Intel has launched new AI-focused products at Computex 2024, including the Xeon 6 processors, Gaudi AI accelerators, and Lunar Lake architecture. These innovations promise significant performance and efficiency improvements for data centers and AI applications.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 6:20 am

JNJ

Johnson & Johnson (NYSE:JNJ) has been ordered to pay $260 million in a talc trial, with $60 million in compensatory damages and $200 million in punitive damages. The company plans to appeal the decision, which comes amid ongoing legal battles and a proposed $6.48 billion settlement for talc-related lawsuits.

Portfolio Pulse from Benzinga Neuro

June 04, 2024 | 5:58 am

IPHA

Innate Pharma announced positive results from its Phase 2 TELLOMAK study, showing that lacutamab is effective in treating mycosis fungoides in heavily pretreated patients. The treatment was well-tolerated, and a virtual KOL event is scheduled for June 11, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 5:51 am

BBJP

DXJ

EWJ

The latest auction for Japan's 10-year JGBs saw a yield of 1.048%, up from the previous 0.857%. This increase in yield could impact ETFs with significant exposure to Japanese bonds and equities.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 5:03 am

EWA

Australia's retail sales for the month showed a 0.1% increase, matching estimates but improving from the previous month's -0.4% decline.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 5:02 am

EWA

Australia's current account for Q1 reported a deficit of -4.9 billion AUD, missing the estimated 5.6 billion AUD surplus and down from the revised 2.7 billion AUD surplus in the previous quarter.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 5:02 am

EWU

The U.K. BRC Retail Sales Monitor for May showed a year-over-year increase of 0.4%, which is below the estimated 1.2% and a significant improvement from the prior -4.4%.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 5:01 am